Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Authors
Keywords
-
Journal
Medicina-Lithuania
Volume 55, Issue 9, Pages 526
Publisher
MDPI AG
Online
2019-08-26
DOI
10.3390/medicina55090526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
- (2019) Maria Maddalena Simile et al. Medicina-Lithuania
- Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
- (2019) Zachary J. Brown et al. HEPATOLOGY
- Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells
- (2018) Yingying Jing et al. CANCER LETTERS
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
- (2018) Jeong-Hoon Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
- (2018) Ozlem Kutlu et al. Canadian Journal of Gastroenterology and Hepatology
- Regorafenib: a promising treatment for hepatocellular carcinoma
- (2018) Lucia Cerrito et al. EXPERT OPINION ON PHARMACOTHERAPY
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- KEYNOTE-240: Randomized phase III study of pembrolizumab versus best supportive care for second-line advanced hepatocellular carcinoma.
- (2017) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
- (2017) Pegah Golabi et al. MEDICINE
- Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism
- (2017) Jitka Soukupova et al. Scientific Reports
- A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
- (2016) W. M. Tai et al. ANNALS OF ONCOLOGY
- Challenges of advanced hepatocellular carcinoma
- (2016) Stefano Colagrande et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Liver Cancer
- (2015) Chun-Yu Liu et al. Cold Spring Harbor Perspectives in Medicine
- Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing
- (2015) Filip Janku et al. Oncotarget
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
- (2014) Samuele De Minicis et al. PLoS One
- Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
- (2014) Gaetano Bertino et al. Biomed Research International
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention
- (2013) ABDU SELIM HAMID et al. Oncology Letters
- From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence
- (2013) Gayatri Ramakrishna et al. Liver Cancer
- Clinical Trials in Hepatocellular Carcinoma: An Update
- (2013) Ying-Chun Shen et al. Liver Cancer
- Molecular Mechanisms of Liver Cancer
- (2012) Hongming Pan et al. Anti-Cancer Agents in Medicinal Chemistry
- Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma
- (2012) Takuji Okusaka et al. CANCER SCIENCE
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
- (2012) Donna L. White et al. Clinical Gastroenterology and Hepatology
- Molecular Targeted Therapies in Hepatocellular Carcinoma
- (2012) Shinji Tanaka et al. SEMINARS IN ONCOLOGY
- Signaling Pathway and Molecular-Targeted Therapy for Hepatocellular Carcinoma
- (2011) Masatoshi Kudo DIGESTIVE DISEASES
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
- (2010) A. P. Venook et al. ONCOLOGIST
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- Hepatitis C Virus and Alcohol
- (2009) Larry Siu et al. SEMINARS IN LIVER DISEASE
- Molecular Mechanisms Underlying Hepatocellular Carcinoma
- (2009) Philippe Merle et al. Viruses-Basel
- Hepatocellular carcinoma and the ubiquitin–proteasome system
- (2008) Simon P. Dawson BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Molecular mechanisms of hepatocellular carcinoma
- (2008) Rajagopal N. Aravalli et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is human hepatocellular carcinoma a hormone-responsive tumor?
- (2008) Massimo Di Maio WORLD JOURNAL OF GASTROENTEROLOGY
- c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1
- (2008) Meryem Güller et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search